Showing results (381-390 of 402) with videos related to
Sort By:
Pageof 41
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 30, 2017
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in RemissionKyoo-Hyung Lee, Je-Hwan Lee, Jung-Hee Lee, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 18, 2016
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute LeukemiaInpyo Choi, Suk Ran Yoon, Soo-Yeon Park, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2017
Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid LeukemiaJe-Hwan Lee, Hawk Kim, Young-Don Joo, et al.Leukemia Research|September 2, 2008
Clinical significance of GSTM1 and GSTT1 polymorphisms in younger patients with acute myeloid leukemia of intermediate-risk cytogeneticsHo Sup Lee, Je-Hwan Lee, Eun-Hye Hur, et al.International Journal of Hematology|February 12, 2013
Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with acute promyelocytic leukemia (APL)Silvia Park, Su Jin Lee, Kihyun Kim, et al.Veterinary and Comparative Oncology|February 22, 2026
Whole Exome Sequencing of Feline Oral Squamous Cell Carcinoma Reveals Genomic Parallels With Human Head and Neck Squamous Cell CarcinomaShirley Chu, Zachary L Skidmore, Wes Warren, et al.Clinical Therapeutics|February 11, 2026
Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical TrialSang Hyun Lee, Kyungil Park, Ki Hong Lee, et al.Annals of Hematology|February 25, 2010
Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinibYoungil Koh, Inho Kim, Sung-Soo Yoon, et al.Leukemia Research|February 1, 2022
The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patientsHyunkyung Park, Sungbong Kang, Inho Kim, et al.Leukemia & Lymphoma|May 8, 2015
Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patientsJoon Seong Park, Sung-Eun Lee, Seong Hyun Jeong, et al.Pageof 41